<DOC>
	<DOCNO>NCT00143143</DOCNO>
	<brief_summary>The primary purpose protocol evaluate long-term safety pregabalin patient partial seizure .</brief_summary>
	<brief_title>Pregabalin Open-Label Extension Trial Patients With Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Epilepsy , Complex Partial</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients must meet inclusion criterion Study 1008157 , receive doubleblind study medication , wish receive openlabel pregabalin Have diagnosis epilepsy partial seizure minimum 4 partial seizure 6 week prior screen Be currently take 1 3 AEDs . Have treatable cause seizure Experienced serious adverse event Study 1008157 determine possibly relate study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2006</verification_date>
</DOC>